MedTrace Logo

Surgery in Treating Patients With Neuroblastoma

NCT00003122 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 210

Last updated 2013-08-26

No results posted yet for this study

Summary

RATIONALE: Surgery may be an effective treatment for neuroblastoma.

PURPOSE: This phase II trial is studying how well surgery works in treating patients with neuroblastoma.

Conditions

Interventions

PROCEDURE

surgical procedure

Sponsors & Collaborators

  • Societe Internationale d'Oncologie Pediatrique

    lead OTHER

Principal Investigators

  • Jean Marie Michon, MD · Institut Curie

Study Design

Purpose
TREATMENT

Eligibility

Max Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1994-12-31

Countries

  • Austria
  • France
  • Ireland
  • Italy
  • Netherlands
  • Spain
  • Switzerland
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00003122 on ClinicalTrials.gov